CLINE CHRISTOPHER R. (CHIEF FINANCIAL OFFICER) sold 1.5% of their position (1.75K shares) of TRAVERE THERAPEUTICS, INC. on the open market
Open‑market sale worth $56.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 2/5/2026ACC: 0001943192-26-000002
Officer· CHIEF FINANCIAL OFFICER
Since Feb 2026
-1.75K
Net shares
Net seller
$56.2K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
1.75K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−1.64K
Price / share
$32.14
Trade value
$52.55K
% of position
1.4%
2/4/2026
112.97K→111.34K
Common Stock
Direct
Shares
−110.00
Price / share
$32.90
Trade value
$3.62K
% of position
0.1%
2/4/2026
111.34K→111.23K
Total
Net shares
−1.75K
Net value
-$56.17K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/4/2026 | S · Sale | −1.64K | $32.14 | $52.55K | 1.4% | 112.97K | 111.34K |
| Common Stock Direct | 2/4/2026 | S · Sale | −110.00 | $32.90 | $3.62K | 0.1% | 111.34K | 111.23K |
| Total | −1.75K | -$56.17K | ||||||
Derivative Transactions0
No derivative transactions reported